Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease
A completed clinical trial update examining whether overactive bladder in elderly patients may act as an early indicator of coronary artery …
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Combined Behavioral and Drug Treatment of Overactive Bladder in Men [Phase 2, Phase 3]
This report summarizes a completed Phase 2/Phase 3 clinical trial evaluating a combined behavioral therapy and drug treatment for overactive…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder [Phase 4]
A Phase 4 study examines the efficacy, safety, and tolerability of darifenacin in patients over 65 with overactive bladder.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
A pilot study investigated whether subacute urinary tract infections contribute to overactive bladder; the study is completed and results we…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Premarin Versus Toviaz for Treatment of Overactive Bladder [Phase 4]
A Phase 4 clinical trial update comparing Premarin (conjugated estrogens) versus Toviaz (fesoterodine) for overactive bladder, sponsored by …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Drug Use Investigation for Toviaz
Clinical trial update for a Pfizer investigation of Toviaz in overactive bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females [NA]
This update reports on a completed clinical trial evaluating transcutaneous posterior tibial nerve electrostimulation combined with low-dose…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation [NA]
Clinical trial update documenting the time to onset of effect for sacral neuromodulation in treating overactive bladder and nonobstructive u…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating the flexible addition of a second antimuscarinic agent to a …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan [Phase 3]
A Phase 3 clinical trial of mirabegron in Taiwanese patients with overactive bladder and urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome [Phase 2]
A Phase 2 trial evaluating different numbers of injections at the same dose of Botulinum toxin A for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility [Phase 2]
Phase 2 clinical trial evaluating injections of Botulinum toxin type A for detrusor overactivity with impaired contractility; study complete…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) [Phase 4]
Phase 4 trial comparing tolerability and patient preference between mirabegron and tolterodine ER in adults with overactive bladder has comp…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan [Phase 3]
Phase 3 clinical trial update assessing the efficacy and safety of mirabegron for overactive bladder in Taiwan.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug [Phase 3]
A Phase 3 study evaluating the effectiveness and safety of solifenacin succinate suspension for treating overactive bladder in children aged…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder [Phase 2]
GlaxoSmithKline completed a Phase 2 trial comparing GW679769 to placebo in women with overactive bladder. The update indicates the trial is …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB [Phase 3]
Phase 3 clinical trial updating the efficacy and safety of THVD-201 in patients with overactive bladder has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: IVES for Treatment of UUI and OAB [EARLY_Phase 1]
This entry reports the completion of a Phase 1 trial evaluating the drug IVES for overactive bladder and urinary urge incontinence.
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: Efficacy and Safety of Gabapentin in Treating Overactive Bladder [Phase 2, Phase 3]
Gabapentin for overactive bladder has completed Phase 2 and Phase 3 trials assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Utilization of the BIOWAVE Device to Treat Overactive Bladder [NA]
Completed clinical trial update for the BIOWAVE device in the treatment of overactive bladder. Results were posted in December 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Low-level Light Therapy for Overactive Bladder and Urinary Incontinence [Phase 3]
Phase 3 clinical trial update on low-level light therapy for overactive bladder and urinary incontinence; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain [NA]
A terminated clinical trial evaluated preoperative use of darifenacin (Enablex) to alleviate postoperative ureteral stent pain, with results…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Long-Term Specified Drug Use-results Survey of Betanis Tablets
This completed long-term study provides results from a specified-use survey of Betanis tablets for overactive bladder, focusing on safety an…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
An observational study evaluating botulinum toxin type A for urinary incontinence due to overactive bladder (including neurogenic bladder) h…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers [Phase 1]
Phase 1 trial in healthy male volunteers assessing safety and pharmacokinetics of two investigational agents, HIP1503 and HGP1103, with Over…